First PREMIER Bank Has $332,000 Stake in Kenvue Inc. (NYSE:KVUE)

First PREMIER Bank lifted its stake in shares of Kenvue Inc. (NYSE:KVUE) by 18.5% in the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,823 shares of the company’s stock after buying an additional 2,159 shares during the quarter. First PREMIER Bank’s holdings in Kenvue were worth $332,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also bought and sold shares of the company. SRS Capital Advisors Inc. grew its position in Kenvue by 67.4% in the 4th quarter. SRS Capital Advisors Inc. now owns 1,418 shares of the company’s stock valued at $30,000 after purchasing an additional 571 shares during the period. Clarity Asset Management Inc. bought a new position in Kenvue during the 4th quarter valued at $45,000. SBI Securities Co. Ltd. bought a new position in Kenvue during the 4th quarter valued at $46,000. Deseret Mutual Benefit Administrators lifted its stake in Kenvue by 29.0% during the 4th quarter. Deseret Mutual Benefit Administrators now owns 2,528 shares of the company’s stock valued at $54,000 after acquiring an additional 568 shares in the last quarter. Finally, Versant Capital Management Inc lifted its stake in Kenvue by 77.9% during the 1st quarter. Versant Capital Management Inc now owns 3,415 shares of the company’s stock valued at $82,000 after acquiring an additional 1,495 shares in the last quarter. Institutional investors and hedge funds own 97.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on KVUE. Citigroup restated a “neutral” rating on shares of Kenvue in a research note on Friday, June 13th. Barclays lifted their target price on Kenvue from $22.00 to $23.00 and gave the stock an “equal weight” rating in a research note on Monday, May 12th. Redburn Atlantic began coverage on Kenvue in a research note on Thursday, April 10th. They set a “neutral” rating and a $23.50 target price on the stock. UBS Group boosted their price objective on Kenvue from $24.00 to $25.00 and gave the company a “neutral” rating in a research note on Friday, May 9th. Finally, Evercore ISI assumed coverage on Kenvue in a research note on Monday, March 24th. They issued an “in-line” rating and a $25.00 price objective on the stock. Seven equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $25.33.

Kenvue Price Performance

Shares of Kenvue stock opened at $21.39 on Friday. The company has a quick ratio of 0.60, a current ratio of 0.86 and a debt-to-equity ratio of 0.63. The company has a market cap of $41.03 billion, a PE ratio of 38.88, a P/E/G ratio of 3.32 and a beta of 0.98. The business has a 50 day moving average of $23.00 and a 200 day moving average of $22.43. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $25.17.

Kenvue (NYSE:KVUE) last announced its earnings results on Thursday, May 8th. The company reported $0.24 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01. The company had revenue of $3.74 billion during the quarter, compared to the consensus estimate of $3.69 billion. Kenvue had a return on equity of 20.87% and a net margin of 6.90%. The firm’s revenue for the quarter was down 3.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.28 earnings per share. As a group, equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 28th. Stockholders of record on Wednesday, May 14th were paid a $0.205 dividend. The ex-dividend date was Wednesday, May 14th. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.83%. Kenvue’s dividend payout ratio is currently 149.09%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.